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Abstract
Sensory ataxic neuropathy (SAN) is a recently identified neurological disorder in golden retrievers. Pedigree analysis
revealed that all affected dogs belong to one maternal lineage, and a statistical analysis showed that the disorder has a
mitochondrial origin. A one base pair deletion in the mitochondrial tRNA
Tyr gene was identified at position 5304 in affected
dogs after re-sequencing the complete mitochondrial genome of seven individuals. The deletion was not found among
dogs representing 18 different breeds or in six wolves, ruling out this as a common polymorphism. The mutation could be
traced back to a common ancestor of all affected dogs that lived in the 1970s. We used a quantitative oligonucleotide
ligation assay to establish the degree of heteroplasmy in blood and tissue samples from affected dogs and controls.
Affected dogs and their first to fourth degree relatives had 0–11% wild-type (wt) sequence, while more distant relatives
ranged between 5% and 60% wt sequence and all unrelated golden retrievers had 100% wt sequence. Northern blot
analysis showed that tRNA
Tyr had a 10-fold lower steady-state level in affected dogs compared with controls. Four out of five
affected dogs showed decreases in mitochondrial ATP production rates and respiratory chain enzyme activities together
with morphological alterations in muscle tissue, resembling the changes reported in human mitochondrial pathology.
Altogether, these results provide conclusive evidence that the deletion in the mitochondrial tRNA
Tyr gene is the causative
mutation for SAN.
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Introduction
Sensory ataxic neuropathy (SAN) is a recently identified
neurological disorder in golden retrievers [1]. SAN has an
insidious onset during puppyhood, followed by slow progression.
Males and females are affected at similar frequencies. Affected
dogs are ataxic, have postural reaction deficits and reduced or
absent spinal reflexes. They have no pronounced muscle atrophy,
and the dogs do not seem to be in pain. Electrophysiological
examination revealed that they have reduced conduction velocities
of nerve impulses in sensory nerves. Pathological examination
indicated degenerative changes both in the central and peripheral
nervous system. Approximately fifty percent of the affected dogs
were euthanized before three years of age. A preliminary
examination of pedigree data showed that all affected dogs could
be traced back to a female on the maternal side that lived in the
1970s, suggesting that SAN could be caused by a mutation in the
mitochondrial genome (mtDNA).
Mitochondrial disorders, caused by mutations in maternally
inherited mtDNA, are a group of heterogeneous diseases in
humans. More than 250 pathogenic point mutations as well as
small and large scale rearrangements of mtDNA have been
identified [2], and with an estimated incidence of approximately 1
in 8000 in the Caucasian population, mitochondrial disorders are
considered to be among the most common forms of metabolic
disease [3]. They usually manifest in energy-consuming tissues
such as the central nervous system, muscles, auditory system and
visual system, but almost any organ in any combination might be
involved and age at onset often varies widely.
The genotype/phenotype relationship for mtDNA mutation
diseases is only partly understood. A somatic mammalian cell
typically contains thousands of mtDNA molecules. Typically only
one type of mtDNA is present in a cell, a condition referred to as
homoplasmy. In mitochondrial diseases and in ageing a mixture of
wild-type and mutated mtDNA may be simultaneously present in
a cell, a condition referred to as heteroplasmy [4–6]. Mutated
mtDNA will only impair respiratory chain function if it is present
at a minimal threshold level. Furthermore, the relative proportion
of wild-type and mutated mtDNA may vary widely between tissues
in an individual. The disease manifestation in these disorders will
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(mutation levels and distribution) and the nuclear genetic
background. A well-known example of the interplay between
mutated mtDNA and nuclear genes is Leber’s hereditary optic
neuropathy (LHON), where the reduced penetrance of the
phenotype is influenced by nuclear loci [7].
Two thirds of disease-causing mtDNA mutations occur in tRNA
genes, which only constitute approximately 9% of the mitochon-
drial genome. This suggests that tRNA genes are ‘‘hotspots’’ for
mitochondrial mutation [8,9]. Experimental studies in the mouse
supports this idea and has shown that tRNA gene mutations are
much more likely to be maternally transmitted than mutations in
protein coding genes [10]. The tRNA mutations typically are
heteroplasmic and affect mitochondrial translation, thereby
causing reduced expression of all mtDNA-encoded proteins.
However, impaired translation and respiratory chain deficiency
will only occur if the level of mutated mtDNA exceeds a certain
threshold.
Several animal models are available that mimic the pathologic
state of mitochondrial disorders in humans [11,12]. Very few of
them do however resemble a natural situation that allows the
inheritance of a single tRNA mutation to be studied over several
generations. We here show that SAN in golden retrievers is caused
by a mutation in the mitochondrial tRNA
Tyr gene. Thanks to a
detailed breeding registry, we were able to trace the mutation
more than 10 generations back in time.
Results
Pedigree Analysis and Re-Sequencing
Pedigree analysis of the 25 affected dogs revealed that they all
belong to the same maternal lineage, and can be traced back to a
female X that lived during the 1970s (Figure 1). In order to test if
these data exclude a possible nuclear inheritance we calculated the
prevalence of disease in offspring from all males and females in
those litters where the mothers to the affected dogs were one of the
siblings. If the risk factor was present in the nuclear genome, the
proportion of affected progeny should be about the same from
male and female parents in this maternal lineage. By contrast, all
cases should derive from female parents if the risk factor is
encoded in the mtDNA genome. We observed 25 affected dogs
among 272 progeny from female dogs but no affected dogs among
177 progeny sired by males (P,10
26; Fisher’s exact test). This
provides conclusive evidence that SAN shows mitochondrial
transmission.
We re-sequenced the complete mitochondrial genome of seven
dogs: four affected golden retrievers (GRs), one close relative and
two unrelated GRs. A one base pair deletion was identified at
position 5304 in tRNA
Tyr of the affected dogs and their relatives
(Figure 2A). This was the only sequence variant that was uniquely
associated with the disease. This variant has not been found in any
other dog breed and this position in mtDNA is highly conserved
among vertebrates.
Assessment of Heteroplasmy
We evaluated two different methods, pyrosequencing and
quantitative oligonucleotide ligation assay (qOLA), to quantify the
level of heteroplasmy of the deletion in the tRNA
Tyr gene (Text S1;
Figure S1). The qOLA method provided superior resolution and
was therefore applied (Figure 2B). We had access to blood samples
from 20 out of the 25 affected golden retrievers, and from 13 first,
second, third or fourth degree relatives that did not display the
clinical disease phenotype. Additional more distant relatives (n=8)
descendant from female Z were also analyzed (Figure 1). We were
unable to collect any blood samples tracing further back than to
female Z because these dogs are either dead or the registry is
incomplete. We also searched for the deletion in 71 healthy
unrelated golden retrievers, in 86 dogs representing 18 other breeds
and in six wolfs. All unrelated dogs had 100% wt sequence, whereas
among the distant relatives (tracing back to female Z, but not to
female X; Figure 1) we observed a large variation in mutation load,
ranging from 5–60% wt, indicating that female X that we initially
assumed to be the founder was in fact not. The affected individuals
had a very low level of wt sequence (0–11.2%). Low levels of wt
sequences were also found among clinically healthy close relatives,
and the proportion of % wt sequence overlapped between the two
groups (Figure 2B). There was no strong correlation between the
degree of heteroplasmy and the degree of relatedness among close
relatives. Thus, this very sensitive test did not unambiguously
distinguishaffectedindividualsfromtheircloserelativesthatshowed
no clinical signs of disease when analyzed in blood.
We also analyzed the degree of heteroplasmy in different tissues
from three affected dogs. The frontal lobe, spinal cord with dorsal
root ganglia (7
th thoracal and 5
th lumbar), optic nerve, recurrent
laryngeal nerve, pancreas, thyroid gland, and skeletal muscle of
both pelvic and thoracic limb were analyzed by qOLA. The results
revealed that all analyzed tissues had a higher mutation load, close
to 0% wt, compared with that found in blood cells from the same
affected individuals. Unfortunately, we do not have access to
tissues from clinically healthy relatives with a similarly high
mutation load as that found in the affected dogs.
Northern Blot Analysis
Steady-state levelsof three mtDNAtRNAspecies wereassessed by
northern blot analysis. Analysis of tRNAs extracted from muscle
tissue of three SAN-affected dogs and two controls, a dachshund
and a healthy golden retriever, showed that all three SAN-affected
dogs had significantlyreduced levelsoftRNA
Tyr comparedtothetwo
controls (Figure 2C); the hybridization intensity was on average
about 10-fold lower than for controls (P,0.001 in a student’s t-test).
In contrast, all affected dogs showed normal expression of tRNA
Cys
and tRNA
Gln compared with the controls (Figure 2C).
Structure Probing
In vitro transcribed wt and mutant tRNA
Tyr wasradioactivelylabeled
at the 59-end and subjected to partial digestion using either lead (Pb
2+)
Author Summary
Mitochondrial disorders are a group of heterogeneous
diseases. It has been estimated that the prevalence of
mitochondrial diseases in humans, due to mutations of the
mitochondrial genome (mtDNA), is approximately 1 in 8000
in a Caucasian population. Since the late 1980s, when the
first disease-causing mutation in human mtDNA was
identified, approximately 250 pathogenic mtDNA muta-
tions have been described. Sensory ataxic neuropathy
(SAN) is a recently identified neurological disorder in
golden retriever dogs that is maternally transmitted.
Affected dogs are ataxic, have postural reaction deficits,
and exhibit reduced spinal reflexes. They have no
pronounced muscle atrophy nor do they seem to be in
pain. In this study, we report the identification and
characterization of the mutation causing SAN, a single
base pair deletion in the mitochondrial tRNA
Tyr gene. The
identification of this mutation makes it possible to
eradicate the disease in golden retrievers. SAN constitutes
a new animal model for mitochondrial disorders in humans.
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significant structural differences between the two molecules.
Mitochondrial ATP-Production Rate and Respiratory
Chain Enzyme Activity
We found a decreased rate of ATP production in isolated
muscle mitochondria from affected animals (Figure 3A; Table S1).
This decrease was most pronounced with the substrate combina-
tions N,N,N
1,N
1-tetramethyl-1,4-phenyldiamine (TMPD)+ascor-
bate (246%) and pyruvate+malate (232%). TMPD+ascorbate is
an artificial electron carrier that acts directly on Complex IV in
the respiratory chain, thus selectively measuring the ATP
producing capacity in Complex IV and V. ATP production from
pyruvate+malate involves all enzymes in Krebs cycle and the
respiratory chain. Maximal endogenous ATP production, ob-
Figure 1. A schematic pedigree of golden retrievers affected by sensory ataxic neuropathy (SAN) and their relatives. In total we had
access to blood samples from 20 out of 25 affected dogs (marked red or black) that can be traced back on the maternal side to female X. We also had
access to samples from 13 first, second, third or fourth degree relatives of affected dogs (marked yellow). More distant relatives descendant of
females Y or Z are marked with green. Only litters with affected dogs and sampled litters are included.
doi:10.1371/journal.pgen.1000499.g001
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Measurement of the activities of different respiratory chain
enzyme complexes showed decreased activities of complex I
(263%), complex I–III (253%) and complex IV (259%) in the
affected dogs in comparison with healthy controls (Figure 3B;
Table S1). The two measurements involving Complex II did not
show significantly altered activities. Measurements of the enzyme
activities of respiratory chain complexes and the ATP production
rate thus gave consistent results indicating dysfunction of complex
I and IV, which are dependent on subunits encoded by
mitochondrial DNA for their function. The function of complex
II is only dependent on nuclear genes and was normal. There was
an elevation of citrate synthase activity in the muscle tissue (+47%)
(Figure 3B) consistent with a mitochondrial proliferation often
observed in respiratory chain deficient tissues.
One of the five affected animals that contributed to the data
presented in Figure 3 did neither show decreases in ATP
production nor in respiratory chain enzyme activities, and was
therefore not possible to distinguish from the healthy controls with
these assays.
Histochemistry and Electron Microscopy of Muscle Fibers
Hematoxylin-eosin staining showed normal morphology for all
examined biopsies. For the oxidative enzymes the reactions were
more even and compact over the cut surface of the fibers for four
of the affected dogs and in one control healthy dog (Table S1). In
Figure 2. Characterization of the DT5304 deletion in the tRNA
Tyr gene. (A) The mutation deleted the A of the innermost base pair of the TYC
stem, as indicated in the cloverleaf structure of tRNA
Tyr. (B) A quantitative oligonucleotide ligation assay (qOLA) was used to estimate the relation
between wild-type and mutant molecules in blood samples from golden retrievers. W represents 71 unrelated golden retriever dogs that all show
100% wt molecules. The green bars represent the degree of heteroplasmy of distant relatives (34.8 (22.0); mean (SD)), yellow bars stand for close
relatives (5.1 (2.8)) and the red bars represent affected dogs (4.9 (3.5)). (C) Northern blot analyses using probes for mt tRNA
Tyr,m ttRNA
Cys and mt
tRNA
Gln and RNA from three SAN-affected golden retrievers and two unaffected dogs; one dachshund (Control 1) and one golden retriever (Control
2). The values given at the bottom of the blots for mt tRNA
Tyr and mt tRNA
Cys is the relative hybridization intensity normalized using the hybridization
intensity for mt tRNA
Gln. The sample with the highest normalized hybridization intensity was given the value 1.00.
doi:10.1371/journal.pgen.1000499.g002
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cytochrome oxidase (COX) these also showed a bluish staining
compared with the controls and affected dog nr. 3 (Figures 4A and
B). Fibers showing total lack of cytochrome oxidase activity were
not detected.
Electron microscopy revealed only clear signs of mitochondrial
pathology for one of the dogs (affected dog nr. 3), which in light
microscopy however did not show the bluish staining in the
combined SDH/COX reaction. Paracrystalline inclusions were
present in some of the fibers of this dog (Figures 4C and D).
Discussion
The pedigree analysis provided conclusive evidence that SAN is
a maternally inherited disorder. Re-sequencing of the complete
mtDNA revealed a one base pair deletion in the mt tRNA
Tyr gene
in a region that is conserved across mammalian species. A qOLA
assay of the proportion of mutant and wild-type mtDNA showed
that the different groups of dogs carry different mutation load,
however the mutation load in blood of affected dogs and their
close relatives overlap. The lack of a perfect correlation between
our estimate of heteroplasmy and the clinical phenotype is most
likely due to the fact that the disease is manifested in the CNS
while we measured the mutation load in blood cells. It is well
known that the nuclear genetic background can affect the
penetrance of pathogenic mtDNA mutations and it can therefore
not be ruled out that nuclear polymorphisms as well as
unidentified environmental factors may contribute to the risk of
disease manifestation.
More distant relatives (tracing back to female Y and Z) showed a
larger variation in mutation load and a higher fraction of wild-type
copies compared to dogs traced back to female X (Figure 2B). The
fact that disease only occurred in the branch of the pedigree with
the highest proportion of the one base-pair deletion in tRNA
Tyr
supports that this is the causative mutation.
Northern blot analysis demonstrated lower steady-state levels of
tRNA
Tyr in muscle tissue from affected dogs, compared to healthy
controls. This can either be explained by a processing defect
impairing the formation of the mature tRNA
Tyr or by an increased
turnover of the mutant tRNA
Tyr. We can refute the former option.
Firstly, northern blots with probes detecting tRNA
Tyr showed no
additional high molecular weight RNAs indicative of aberrant
Figure 3. Mitochondrial ATP production and respiratory chain enzyme activity. Biochemical analyses of respiratory chain function in
affected (filled bars) and control (open bars) animals. Bars represent mean levels 6SEM. n=5 in both groups. *, P,0.05; **, P,0.01. (A) Mitochondrial
ATP production rate in the presence of the substrate combinations glutamate+succinate, TMPD+ascorbate, pyruvate+malate, palmitoyl-L-
carnitine+malate and succinate+rotenone, which enter the respiratory chain at different points. (B) Relative activities of citrate synthase (CS) in muscle
tissue and respiratory chain enzymes in isolated mitochondria. NADH coenzyme Q reductase (NQR), corresponding to complex I; NADH cytochrome c
reductase (NCR), complex I–III; succinate dehydrogenase (SDH), complex II; succinate cytochrome c reductase (SCR), complex II–III; cytochrome c
oxidase (COX), complex IV. The relative enzyme activities presented as 100% in the figure correspond to the following absolute values: CS 61 mmol/
min/kg muscle, NQR 0.13, NCR 1.4, SDH 0.36, SCR 0.76 and COX 2.8 units/unit CS. Raw data for individual dogs are given in Table S1.
doi:10.1371/journal.pgen.1000499.g003
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Tyr and tRNA
Cys are transcribed as a
polycistronic precursor and a processing defect should affect both
molecules. The fact that the steady state level of tRNA
Cys appears
unaffected argues strongly against an aberrant processing. Thus,
our data indicate that the deletion impairs the stability of the
mutated tRNA
Tyr.
Although the affected animals did not show any obvious overt
clinical signs in muscle, a severely affected muscle mitochondrial
function was observed in a majority of the examined individuals.
The decreases in mitochondrial ATP production and in the
respiratory chain activities of complex I and IV are all findings
consistent with alterations found in humans and mice affected by
mtDNA disorders [11,13–15]. Increased citrate synthase activity is
frequently observed in mitochondrial disorders and is thought to
reflect mitochondrial proliferation in response to energy deficit in
the diseased tissue [12,15]. One of the affected dogs had nearly
normal respiratory chain enzyme activities, possibly due to a
mosaic tissue distribution of the heteroplasmy [16].
The disturbed muscle mitochondrial function was accompanied
by a divergent pattern in the combined histochemical staining for
cytochrome c oxidase (COX) and succinate dehydrogenase (SDH).
The affected animals showed a bluish staining, indicating a shift
towards a lower COX activity compared to the SDH activity.
Fibers totally lacking COX-activity and ragged red fibers are
common findings in humans harboring large scale deletions and
tRNA mutations in mtDNA [13,14,17]. Strikingly, no such fibers
were found in muscle samples from the dogs. A possible
explanation for this observation and the fact that SAN-affected
dogs did not have any clinical overt signs of muscle disease, might
be the different muscle composition in dogs, with a higher
mitochondrial density compared to humans [18]. Despite the lack
of ragged red fibers, mitochondrial paracrystalline inclusions were
found in one of the animals, a characteristic finding in human
adult mitochondrial myopathies [17]. Since dogs have been
euthanized before they have acquired life-threatening clinical
signs, the end stage pathology of the disease is unknown.
According to DiMauro & Davidzon (2005) [19] a mitochondrial
mutation is likely to be pathogenic if 1) the mutation is not present
in healthy normal individuals, 2) it changes an evolutionarily
conserved site, 3) the mutation causes a respiratory chain enzyme
deficiency in affected tissues or defects in mitochondrial protein
synthesis and respiration demonstrable in cybrid cell lines, and 4) a
correlation between heteroplasmy and clinical phenotype is
observed. The deletion reported in this study fulfills all the criteria
listed above, except for the first one, as we observed clinically
healthy, close relatives with high mutation load. However, some
exceptional cases of pathogenic mutations that are homoplasmic in
non-affected humans have also been reported [6,20]. Further-
more, all cases in the present occurred in the part of the pedigree
with the highest mutation load and all unrelated dogs were 100%
Figure 4. Histochemistry and electron microscopy of muscle fibers from SAN-affected (B, C and D) and control dogs (A). (A and B)
Histochemistry showing the combined reaction for SDH and COX. Note the bluish reaction for the affected dog, indicating lack of COX activity.
Bar=200 mm. (C and D) Electron microscopy showing paracrystalline inclusions in a case. Bar=0.5 mm.
doi:10.1371/journal.pgen.1000499.g004
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Tyr. Thus, this study has
provided conclusive evidence that SAN is a mitochondrial disorder
and that DT5304 in tRNA
Tyr is the causative mutation.
This is the second report of an mtDNA disorder in dogs. In a
previous study, Li et al. (2006) identified a mutation in the
mitochondrial cytochrome b gene that is associated with encepha-
lomyelopathy in families of Shetland sheepdogs and Australian
cattle dogs [21]. Other studies reporting suspected mitochondrial
disorders in dogs (i.e. mitochondrial myopathies or encephalopa-
thies) are based on single or few cases and are restricted to clinical,
pathological and biochemical aspects of the disorders, thus not
including complete or partial mtDNA sequencing to identify the
disease-causing mutation [22–24].
In humans, mutations in the mitochondrial tRNA
Tyr gene have
been associated with mitochondrial disorders [25–28]. These cases
involve mutations at other positions (A5843G, A5874G, G5877A
and DT5885,) than the one associated with SAN in dogs (DT5304),
which corresponds to position 5848 in humans. Sahashi et al. [25]
and Raffelsberger et al. [26] described two female patients with
CPEO (chronic progressive external ophthalmoplegia) with age of
onset at 28 and 41 years of age and exercise intolerance, whereas
Scaglia et al. [27] reported a female patient with mitochondrial
cytopathy progressing to focal segmental glomerulosclerosis and
cardiomyopathy. Similar clinical signs have not been observed in
the golden retrievers reported in this study.
This study documents one of the most extensive pedigrees with
a mtDNA disorder in any species. We identified 25 affected dogs
and traced the mutation back at least to female Z (Figure 1), born
in 1971. It has been transmitted silently since then, and the first
case of an affected dog identified by us was born 1997. Based on
information from the studbook we estimate that about 5% of
female dogs in the Swedish golden retriever population born
2001–2005 carry this mutation. The prevalence in other countries
is at present unknown because we were not able to trace the
mutation further back than to female Z. The most interesting
aspect of this study is the mild phenotypic effect of the mutation
which allows very high mutation loads (down to almost 0% wild-
type sequence in blood cells) in clinically healthy individuals. It
therefore constitutes an interesting model for human mtDNA
disorders that may be used for testing therapeutic approaches for
treating mitochondrial disorders.
Materials and Methods
Animal Tissues
Blood and tissue samples were collected from privately owned dogs
withtheownerswrittenconsent. Theextracted DNA(QIAamp DNA
B l o o dM i n iK i t ,Q i a g e n ,V a l e n c i a ,C A )w a sk e p ta t220uC until it
was used. Tissue samples were collected in immediate conjunction
with euthanasia, at the Swedish National Veterinary Institute,
Uppsala, Sweden, and were kept at 280uCp r i o rt ou s e .F r e s h
muscle biopsies for functional studies, electronmicroscopy and
histopathology were collected from m. quadriceps vastus medialis of five
affected dogs (1–5 years of age) and five age-matched control GR
dogs under sedation and local anesthesia. The study was approved by
Uppsala Animal Ethics Committee.
Pedigree Analysis
The pedigree was analyzed using information of relatedness
from the Swedish Kennel Club registry (www.skk.se).
mtDNA Re-Sequencing
The complete mitochondrial genome was re-sequenced from
fifteen overlapping amplicons. All PCR primers generated
amplicons ranging from approximately 1200–1500 bp and were
designed using the Primer3 software [29]. The PCR primers were
reused for sequencing together with four additional internal
sequencing primers per amplicon (Table S2). Contigs were aligned
and analyzed using Codon Code (Dedham, MA). Complete
mitochondrial sequences of four affected dogs (GenBank
FJ817358, FJ817359, FJ817360, FJ817361), one close relative
(FJ817362) and two unrelated golden retrievers (FJ817363,
FJ817364) have been deposited in GenBank. The numbering of
nucleotide positions refers to the complete dog mtDNA sequence
with GenBank accession number NC_002008.
Quantification of tRNA
Tyr Deletion
Quantitative oligonucleotide ligation assay (qOLA) method was
used to estimate the mutation load in blood and tissue samples, but
also for evaluation purposes. Each sample was PCR-amplified
according to standard procedure using the primers listed in Table
S3. PCR products were treated with proteinase K (20 ng/ul) at
98uC for 1 h and then used for a ligation reaction containing
16Reaction buffer, 1 pmol F-primer, 0.5 pmol R1-primer,
0.5 pmol R2-primer, 1.5 U Ampligase Epicentre Biotechnologies,
Madison, WI) at 94uC 10 min, 10 cycles at 94uC 30 s and 50uC
1.5 min. The ligation products were separated using capillary gel
electrophoresis on a MegaBACE (GE Healthcare, Uppsala,
Sweden) and analyzed using MegaBACE Fragment Profiler
Version 1.2. All blood samples, except two, were analyzed in
triplicates. Dogs representing the following 18 breeds were also
analyzed for the presence of the mutation: hovawarts (n=5), giant
schnauzers (n=4), dachshunds (n=7), Nova Scotia duck tolling
retrievers (n=5), boxers (n=5), fox terriers (n=4), Dalmatians
(n=4), basenjis (n=4), Bernese mountain dogs (n=4), border
collies (n=4), bullterriers (n=5), beagles (n=5), shar peis (n=5),
poodles (n=5), bearded collies (n=5), Irish wolfhounds (n=5),
German shepherds (n=5) and West Highland white terriers
(n=5).
Northern Blot
Total RNA was extracted using the mirVana miRNA Isolation
Kit (Ambion, Austin, TX). One mg of RNA was denatured in
formamide loading dye (FD; 90% formamide, 15 mM EDTA,
0.05% bromophenol blue, 0.05% xylene cyanol), boiled, loaded
and run on a 12.5% denaturing polyacrylamide gel. A labeled
pUC19 RNA ladder (Fermentas, Burlington, Canada) was used as
size marker. The RNA was electroblotted onto Nylon N+
membranes (GE Healthcare) at 10 V for 15 h. Transfer was
performed in a Biorad blotting chamber in 16TBE buffer at 4uC.
Prehybridization was done for 2–4 h at 60uCi n1 5 m l
prehybridization buffer (56SSC, 1006Denhardt, 50 mM sodium
phosphate pH 6.7, 1% dextran sulphate, 0.1% SDS) with 75 ml
Herring sperm DNA (20 mg/ml). Hybridization was performed
o/n at 60uC in the same buffer lacking Herring sperm DNA but
containing labeled oligonucleotide probe. Probes were labeled
(40 pmol probe, 106 kinase buffer, T4 polynucleotide kinase
(PNK, Ambion, Austin, TX), [c-
32P]ATP) at 37uC for 45 min.
Prior to hybridization, the labeled probe was run through a G-50
column (GE, Healthcare, Uppsala, Sweden). Probe sequences are
listed in Table S4. Membranes were washed once for 20 min at
60uCi n2 6SSC, 0.5% SDS, and once for 20 min in 0.56SSC,
0.5% SDS. Signals were detected and quantified using a
Molecular Dynamics PhosphorImager model 400S (Sunnyvale,
CA) and ImageQuant software version 4.2a. The hybridization
intensities of tRNA
Tyr and tRNA
Cys were normalized using the
hybridization intensity obtained for tRNA
Gln from the same dog.
Sensory Ataxic Neuropathy in Golden Retriever Dogs
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PCR-amplified products of one affected and one unrelated GR
were cloned using the TOPO TA Cloning kit (Invitrogen,
Carlsbad, CA). The forward primer contained a T7 RNA
polymerase promoter sequence tag to generate in vitro transcription
templates (Table S5). Sequence validated PCR-products (wt or
mutant) were used in in vitro transcription reaction NTPs (25 mM),
46 Trx buffer, RNA guard, T7 RNA polymerase (200 U/ml,
Ambion, Austin, TX) at 37uC for 4 h. RQ1 DNAse was added
(37uC at 30 min) to remove the DNA template, followed by
phenol/chloroform extraction and EtOH precipitation. The RNA
was spun through a G-50 column (GE Healthcare, Uppsala,
Sweden) and dephosphorylated (40 pmol RNA, 106 shrimp
alkaline phosphatase [SAP] buffer, and SAP at 37uC, 1 h). After
an additional phenol/chloroform treatment and precipitation,
redissolved RNA was 59-end labeled by treatment with polynu-
cleotide kinase (40 pmol RNA, 106 kinase buffer, PNK,
[c-
32P]ATP at 37uC for 1 h) and separated on a 8% denaturing
polyacrylamide (PA) gel (1 mg of RNA/lane).
After short exposure to X-ray film, the RNA-containing gel
slices were excised and eluted by shaking o/n in RNA elution
buffer (0.1 M sodium acetate pH 5.6, 10 mM EDTA, 0.5% SDS).
Following phenol/chloroform extraction and EtOH precipitation,
one ml aliquots of the redissolved RNAs (wt and mutant) were used
for preparation of alkaline ladders (OH-ladder), T1-ladder,
Control (untreated), or for partial digestion under native
conditions by RNase T1 (0.01 U, Ambion, Austin, TX) or Pb
2+
(25 mM) according to Table S6. Reactions and subsequent steps
were carried out as described [30]. The RNA samples were run on
a 12% PA-gel (40 W, 1.5 h), followed by transfer to a filter paper,
vacuum dried (SGD5040 Slab Gel Dryer, ArtisanScientific,
Champaign, IL), and analyzed by PhosphorImager as above.
Mitochondrial ATP-Production Rate and Respiratory
Chain Enzyme Activity
Mitochondria were isolated from the fresh muscle tissue, and
respiratory chain enzyme activities and mitochondrial ATP
production rates (MAPR) were determined blindly as described
[31]. Citrate synthase activity in muscle tissue and in isolated
mitochondria was determined according to the same paper.
Histochemistry, Light, and Electron Microscopy
The muscle biopsies were rapidly frozen in 2-Methylbutane/ice.
Eight mm thick cryosections were stained with hematoxylin-eosin
and Gomori trichrome as well as for oxidative enzymes (NADH-
tetrazolium reductase, succinate dehydrogenase, cytochrome
oxidase and the combined reaction for succinate dehydrogenase
and cytochrome oxidase). Pairs of biopsies (one case and one
control) were stained at the same occasion. Muscle samples were
also fixed in 2.5% glutaraldehyde for electron microscopy.
Supporting Information
Figure S1 Evaluation of quantification methods: pyrosequen-
cing and quantitative oligonucleotide ligation assay (qOLA). (A)
Pyrosequencing of wide dilution series. (B) Pyrosequencing of
narrow dilution series. (C) qOLA of wide dilution series. (D) qOLA
of wide dilution series. By comparing the opposite extremes (0 and
100%) of dilution series of Fig. S1 A and C, it is apparent that
qOLA gives a more accurate estimate of these values. This is
further confirmed by comparing Figure S1B and D, where the
linearity is obvious in D, but not in B.
Found at: doi:10.1371/journal.pgen.1000499.s001 (0.25 MB TIF)
Figure S2 Structure probing of tRNA
Tyr. Transfer RNA
Tyr was in
vitro transcribed, labeled and cleaved with RNase T1 or Pb
2+.B y
comparing lanes from wt and mutant there is no obvious alteration
in the structure of the mutant tRNA
Tyr.
Found at: doi:10.1371/journal.pgen.1000499.s002 (4.46 MB TIF)
Table S1 Overview of heteroplasmy in blood and muscle, and
morphological and biochemical examination in the five dog pairs
tested.
Found at: doi:10.1371/journal.pgen.1000499.s003 (0.05 MB
DOC)
Table S2 PCR and sequencing primers.
Found at: doi:10.1371/journal.pgen.1000499.s004 (0.10 MB
DOC)
Table S3 Quantification primers.
Found at: doi:10.1371/journal.pgen.1000499.s005 (0.03 MB
DOC)
Table S4 Northern probes.
Found at: doi:10.1371/journal.pgen.1000499.s006 (0.02 MB
DOC)
Table S5 Structure probing sequences.
Found at: doi:10.1371/journal.pgen.1000499.s007 (0.03 MB TIF)
Table S6 Preparation of OH-ladder, T1-ladder, Control, T1
(0.01 U), Pb
2+ (25 mM).
Found at: doi:10.1371/journal.pgen.1000499.s008 (0.04 MB
DOC)
Text S1 Evaluation of quantification methods - pyrosequencing
and quantitative oligonucleotide ligation assay.
Found at: doi:10.1371/journal.pgen.1000499.s009 (0.02 MB
DOC)
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